IDEA Pharma
- Company typePrivate
- Founded1999
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
IDEA Pharma firmographics
Firmographics- Name
- IDEA Pharma
- Legal name
- IDEA Pharma, a division of SAI MedPartners
- Website
- https://ideapharma.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
IDEA Pharma industry classification
Industry- Product category
- Pharmaceutical Strategy Consulting
- NAICS
- Management Consulting Services (54161), Marketing Consulting Services (541613)
- SIC
- Services-Management Consulting Services (8742)
- akta.pro primary industry
- Healthcare/Pharma Creative Agencies (MPAAAAAJ)
Keywords
Where IDEA Pharma is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
IDEA Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Strategic Consulting Services: IDEA Pharma generates revenue through providing strategic consultancy services to pharmaceutical and biotech companies. Services include positioning strategy, path-to-market strategy, commercial strategy development, and decision intelligence. The company operates on a project-based consulting model with fees for strategic advisory engagements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
IDEA Pharma product offering
Product offeringCore offering
IDEA Pharma is a strategic consultancy that delivers positioning and path-to-market strategy for biopharma clients from early through late phase development. Offerings include Strategic Positioning Services, Path-to-Market Strategy engagements, and a virtual Chief Commercial Officer (vCCO) service for biotech companies. The firm also publishes the annual Global Pharmaceutical Innovation and Invention Index, Digital Innovation Index, and China Pharmaceutical Innovation Index as proprietary research benchmarks.
Product overview
IDEA Pharma is a strategic consultancy (division of SAI MedPartners) providing pharmaceutical innovation expertise, path-to-market strategy, and decision intelligence services. Their core offerings include the Global Pharmaceutical Innovation and Invention Index (tracking top pharma companies' ability to develop and commercialize drugs), the Digital Innovation Index, and the China Pharmaceutical Index. Their Decision Intelligence Approach integrates cross-functional expertise (clinical, regulatory, commercial, analytics, medical) into a stepwise process. The vCCO (virtual Chief Commercial Officer) service provides biotech companies with CCO-level expertise without the full-time hire. Services include strategic positioning, path-to-market strategy, and commercial strategy development.
Differentiator
Problem solved
Functional benefit
Brands
- Pharmaceutical Innovation and Invention Index: Annual ranking of the world's leading pharma companies by their ability to create new ideas and turn them into value, now in its 15th year
- Digital Innovation Index
- China Pharmaceutical Innovation Index
- Virtual Chief Commercial Officer (vCCO)
- IDEA Collider Podcast
- Deep Medicine Podcast
Products and services
- Strategic Positioning Services Best-in-class positioning services delivered to biopharma companies from early through late phase development, providing a robust positioning platform and strategic narrative for drug assets.
- Path-to-Market Strategy Services Path-to-market strategy engagements that define how a biopharma asset will be commercialized, including market shaping, scenario planning, FIVE-X positioning options, and communications platform development.
- vCCO (virtual Chief Commercial Officer) Service Provides biotech companies with the services traditionally performed by a chief commercial officer, combined with consultancy support from a cross-functional team including clinical, regulatory, analytics, medical, and commercial experts.
- Global Pharmaceutical Innovation and Invention Index Annual benchmark ranking the world's leading pharmaceutical companies by their ability to create new ideas and turn them into meaningful outcomes, measuring both invention (raw ideas) and innovation (commercial execution).
- Digital Innovation Index Annual index revealing how top pharmaceutical companies leverage digital advancements to accelerate development, improve patient engagement, and drive impactful change in healthcare.
- China Pharmaceutical Innovation Index Dedicated ranking for the fast-growing Chinese pharmaceutical market, tracking top pharmaceutical companies in China.
Companies that use IDEA Pharma
Customer profileNamed customers10 records
Segments2 records
Ideal customer profiles2 records
IDEA Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
IDEA Pharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Candel TherapeuticscoreStrategic commercial partnership to advance path-to-market commercialization for Candel Therapeutics' lead asset CAN-2409. IDEA provides strategic commercial input throughout development and commercialization process, including commercial strategy development and support for BLA submission in prostate cancer. Partnership expected to run through 2026. Candel retains overall commercial strategy leadership while gaining access to IDEA's cross-functional team expertise in oncology commercialization.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
IDEA Pharma competitors and assessment
Company assessmentDirect peers
- Trinity Life Sciences: Specialist life-sciences commercial strategy and insights firm serving pharma and biotech on launch, positioning, and competitive readiness. Closely comparable in service scope and customer segment to IDEA Pharma.
- Clearview Healthcare Partners: Boutique life-sciences strategy consultancy focused on asset-level commercial strategy, positioning, and launch planning for pharma and biotech. Highly comparable niche specialist competing for similar enterprise and biotech engagements.
- ZS Associates: Large global consulting firm deeply specialized in pharmaceutical and biotech commercial strategy, including sales force, launch, and positioning work. Direct competitor for the same enterprise pharma buyers and strategic-launch engagements.
- SAI MedPartners: Parent company of IDEA Pharma since November 2024. Directly comparable as a life-sciences-focused commercial strategy consultancy offering market research, market access, pricing, and competitive intelligence alongside positioning work.
- Simon-Kucher & Partners (Life Sciences): Global consultancy with deep life-sciences pricing, market access, and commercial strategy expertise. Overlaps directly with IDEA's positioning and path-to-market work, particularly at launch and BD&L stages.
Broad incumbents
- LEK Consulting (Life Sciences Practice): Global strategy consultancy with a long-standing life-sciences specialization, particularly in commercial strategy and pipeline assessment. Directly comparable positioning work for enterprise pharma clients, though at much greater scale.
- IQVIA (Commercial Strategy & Analytics): Global life-sciences technology and services incumbent offering commercial strategy, market access, and real-world evidence to pharma and biotech. Broader portfolio and much larger scale than IDEA but overlapping in positioning and launch strategy.
- Charles River Associates (Life Sciences Practice): Global consulting firm with a dedicated life-sciences practice advising on commercial strategy, pricing, and market access. Larger and broader than IDEA but competes in the same pharma/biotech strategic advisory space.
- McKinsey & Company (Pharma & Medical Products Practice): Global strategy incumbent with a dedicated pharma practice covering R&D, launch, and commercial strategy. Competes for the same enterprise pharma strategic mandates but at a much larger scale and broader scope than IDEA.
- Boston Consulting Group (Healthcare & Biopharma Practice): Global strategy incumbent with a dedicated biopharma practice advising on launch, portfolio, and commercial strategy. Competes for senior-level strategic engagements with the same large pharma clients as IDEA.
Market position
Strengths1 record
Competitive moat4 records
Customer concentration
IDEA Pharma social profiles
Digital presenceIDEA Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
IDEA Pharma leadership team
Management profileNumber of profiles
Profiles3 records
IDEA Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IDEA Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IDEA Pharma
What does IDEA Pharma do?
IDEA Pharma is a strategic consultancy that delivers positioning and path-to-market strategy for biopharma clients from early through late phase development. Offerings include Strategic Positioning Services, Path-to-Market Strategy engagements, and a virtual Chief Commercial Officer (vCCO) service for biotech companies. The firm also publishes the annual Global Pharmaceutical Innovation and Invention Index, Digital Innovation Index, and China Pharmaceutical Innovation Index as proprietary research benchmarks.
Is IDEA Pharma a public or private company?
IDEA Pharma is a private company. It is classified as corporate owned and is currently operating.
When was IDEA Pharma founded?
IDEA Pharma was founded in 1999. It employs 11 to 50 people.
Where is IDEA Pharma based?
IDEA Pharma is headquartered in San Francisco, United States, in the North America region.
How does IDEA Pharma make money?
One revenue line is on record: strategic Consulting Services.
Who are IDEA Pharma's main competitors?
Direct peers on record are Trinity Life Sciences, Clearview Healthcare Partners, ZS Associates, SAI MedPartners and Simon-Kucher & Partners (Life Sciences). Broad incumbents are LEK Consulting (Life Sciences Practice), IQVIA (Commercial Strategy & Analytics), Charles River Associates (Life Sciences Practice), McKinsey & Company (Pharma & Medical Products Practice) and Boston Consulting Group (Healthcare & Biopharma Practice).
Does IDEA Pharma have an API?
No public API is recorded for IDEA Pharma.
What industry is IDEA Pharma in?
IDEA Pharma's product category is Pharmaceutical Strategy Consulting. Its primary akta.pro industry code is MPAAAAAJ, Healthcare/Pharma Creative Agencies. Its NAICS code is 54161 and its SIC code is 8742.